DT
LAB icon

Diversified Trust’s Standard BioTools LAB Stock Holding History

Diversified Trust’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-15,565
Closed -$62K – 679
2020
Q2 		$62K Buy
+15,565
New +$54.2K ﹤0.01% 545
2013
Q4 		$790K Buy
20,625
+7,210
+54% +$212K 0.08% 241
2013
Q3 		$294K Buy
+13,415
New +$264K 0.03% 402

Other funds holding LAB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Atom Investors Austin, Texas $1.4B AUM 23.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Diversified Trust's LAB Position: Q3 2020 in Review

Diversified Trust sold out of Standard BioTools (LAB) in Q3 2020, closing a stake of 15,565 shares — an estimated $62K sold.

Diversified Trust first reported a position in LAB in Q3 2013 and held it in 3 quarters. The position peaked at $790K in Q4 2013. 134 funds tracked by Wall St. Rank hold LAB as of Q3 2020.

  • Diversified Trust reported no remaining Standard BioTools position as of Q3 2020 after selling out during the quarter.
  • Diversified Trust sold 15,565 Standard BioTools shares in Q3 2020, an estimated $62K.
  • Diversified Trust first reported a position in Standard BioTools in Q3 2013 and held it in 3 quarters.
  • Diversified Trust's Standard BioTools position peaked at $790K in Q4 2013.
  • 134 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2020.

Based on Diversified Trust's 13F filing for Q3 2020, filed 15 Oct 2020.